The Patent Finder

Provectus Pharmatech, Inc.

Also on record
Records under this name other than the patents Provectus Pharmatech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.

Back to Provectus Pharmatech, Inc.

PatentTitleStatus Expires Confidence
US 9,422,260Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one(Rose Bengal) and related xanthenes
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,839,688Combination of Rose Bengal and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,426,379Combination of Local and Systemic Therapies for Enhanced Treatment of Dermatologic Conditions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,938,182Halogenated Xanthenes as Vaccine Adjuvants
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,975,106Uses of Halogenated Xanthenes in Oncology and Virology
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,470,296Intracorporeal medicaments for high energy phototherapeutic treatment of disease
Lapsed on the fee record
Ended Jun 25, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jun 25, 2021From the USPTO record
US 7,427,389Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes
Lapsed on the fee record
Ended Sep 23, 2020 · From the USPTO record
Lapsed on the fee recordEnded Sep 23, 2020From the USPTO record
US 7,338,652Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents
Lapsed on the fee record
Ended Mar 4, 2020 · From the USPTO record
Lapsed on the fee recordEnded Mar 4, 2020From the USPTO record
US 8,974,363Topical medicaments and methods for photodynamic treatment of disease
Term ended
Term ended Dec 2, 2019 · From the USPTO record
Term endedTerm ended Dec 2, 2019From the USPTO record
US 6,986,740Ultrasound contrast using halogenated xanthenes
Formerly held
Term ended
Term ended Aug 3, 2019 · From the USPTO record
Term endedTerm ended Aug 3, 2019From the USPTO record
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited